172 related articles for article (PubMed ID: 21412921)
1. Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum.
Martí-Carvajal AJ; Comunián-Carrasco G; Peña-Martí GE
Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD008577. PubMed ID: 21412921
[TBL] [Abstract][Full Text] [Related]
2. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.
Martí-Carvajal AJ; Anand V; Solà I
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD008562. PubMed ID: 26107113
[TBL] [Abstract][Full Text] [Related]
3. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.
Martí-Carvajal AJ; Simancas D; Cardona AF
Cochrane Database Syst Rev; 2011 Jun; (6):CD008562. PubMed ID: 21678379
[TBL] [Abstract][Full Text] [Related]
4. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.
Papageorgiou C; Jourdi G; Adjambri E; Walborn A; Patel P; Fareed J; Elalamy I; Hoppensteadt D; Gerotziafas GT
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):8S-28S. PubMed ID: 30296833
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study.
Yoshihara M; Uno K; Tano S; Mayama M; Ukai M; Kondo S; Kokabu T; Kishigami Y; Oguchi H
Crit Care; 2015 Oct; 19():369. PubMed ID: 26481315
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of the safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation.
Kobayashi T; Kajiki M; Nihashi K; Honda G
Thromb Res; 2017 Nov; 159():109-115. PubMed ID: 29153952
[TBL] [Abstract][Full Text] [Related]
7. Methods for administering subcutaneous heparin during pregnancy.
Sasaki H; Yonemoto N; Hanada N; Mori R
Cochrane Database Syst Rev; 2013 Mar; (3):CD009136. PubMed ID: 23543570
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
[TBL] [Abstract][Full Text] [Related]
10. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
11. Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies.
Ikezoe T
Int J Hematol; 2021 Jan; 113(1):34-44. PubMed ID: 32902759
[TBL] [Abstract][Full Text] [Related]
12. Expert consensus for the treatment of disseminated intravascular coagulation in Japan.
Wada H; Asakura H; Okamoto K; Iba T; Uchiyama T; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S; Kushimoto S; Seki Y; Madoiwa S; Maruyama I; Yoshioka A;
Thromb Res; 2010 Jan; 125(1):6-11. PubMed ID: 19782389
[TBL] [Abstract][Full Text] [Related]
13. Danaparoid: a review of its use in thromboembolic and coagulation disorders.
Ibbotson T; Perry CM
Drugs; 2002; 62(15):2283-314. PubMed ID: 12381232
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial.
Maki M; Terao T; Ikenoue T; Takemura T; Sekiba K; Shirakawa K; Soma H
Gynecol Obstet Invest; 1987; 23(4):230-40. PubMed ID: 3111953
[TBL] [Abstract][Full Text] [Related]
15. The course of disseminated intravascular coagulation is predicted by changes in thrombin-antithrombin III complex levels--is there any difference between treatment with standard heparin or low-molecular-weight heparin?
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):623-7. PubMed ID: 1664251
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation.
Sugawara J; Suenaga K; Hoshiai T; Sato T; Nishigori H; Nagase S; Yaegashi N
Clin Appl Thromb Hemost; 2013 Sep; 19(5):557-61. PubMed ID: 22496090
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors.
Kashiwagi S; Asano Y; Takahashi K; Shibutani M; Amano R; Tomita S; Hirakawa K; Ohira M
Anticancer Res; 2019 May; 39(5):2259-2264. PubMed ID: 31092417
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
Kumura T; Aoyama Y; Ichihara H; Koh S; Mugitani A; Hayakawa H; Yukioka K; Kinoshita D; Nakagawa M; Yamazaki N
Rinsho Ketsueki; 2011 Feb; 52(2):68-72. PubMed ID: 21403426
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors.
Ouchi K; Takahashi S; Chikamatsu S; Ito S; Takahashi Y; Kawai S; Okita A; Kasahara Y; Okada Y; Imai H; Komine K; Saijo K; Takahashi M; Shirota H; Takahashi M; Gamoh M; Ishioka C
Int J Clin Oncol; 2018 Aug; 23(4):790-798. PubMed ID: 29511940
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of recombinant activated factor VIIA (NovoSeven) in case of severe obstetric complication with coagulopathy].
Bielanów T; Sidor M; Maciejewski M; Skrzypek W
Ginekol Pol; 2003 Oct; 74(10):1055-9. PubMed ID: 14669394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]